Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of 0.25mCi PET Imaging for Detecting Cardiac Perfusion
NCT07284576Phase 2Enrolling by invitation
- Sponsor
- Akiva Mintz
- Start
- Dec 2025
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Flurpiridaz F 18 in coronary artery disease (CAD), Myocardial ischemia (MI), myocardial infarction (MI), sponsored by Akiva Mintz. Started Dec 2025; status: enrolling by invitation.
02
Drugs
Flurpiridaz F 18
03
Conditions
coronary artery disease (CAD)Myocardial ischemia (MI)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT07284576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07284576.